QL
KNSA icon

Quarry LP’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Quarry LP’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.3K Sell
110
-160
-59% -$7.09K ﹤0.01% 966
2025
Q4 		$11.1K Sell
270
-856
-76% -$34.3K ﹤0.01% 1348
2025
Q3 		$43.7K Buy
+1,126
New +$36.6K 0.01% 920
2024
Q4 		– Sell
-2,000
Closed -$50K – 1830
2024
Q3 		$50K Buy
+2,000
New +$48.7K 0.01% 734

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Quarry LP's KNSA Position: Q1 2026 in Review

Quarry LP reduced its Kiniksa Pharmaceuticals (KNSA) stake by 59% in Q1 2026, selling an estimated $7.09K and leaving 110 shares worth $5.3K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Quarry LP first reported a position in KNSA in Q3 2024 and has held it in 4 quarters since. The position peaked at $50K in Q3 2024. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Quarry LP held 110 shares of Kiniksa Pharmaceuticals worth $5.3K as of Q1 2026.
  • Quarry LP sold 160 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $7.09K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q1 2026, its #966 holding.
  • Quarry LP first reported a position in Kiniksa Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Quarry LP's Kiniksa Pharmaceuticals position peaked at $50K in Q3 2024.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.